Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pramod Pal

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of the Neurological Sciences|September 27, 2020
Neurological research & training after the easing of lockdown in countries impacted by COVID-19Eng-King Tan, Alberto Albanese, K Ray Chaudhuri, et al.
Neurology India|May 17, 2020
Neurosurgery and Neurology Practices during the Novel COVID-19 Pandemic: A Consensus Statement from IndiaPrakamya Gupta, N Muthukumar, V Rajshekhar, et al.
The Lancet. Neurology|August 16, 2024
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trialStefan Zielen, Thomas Crawford, Luca Benatti, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of the Neurological Sciences|September 27, 2020
Neurological research & training after the easing of lockdown in countries impacted by COVID-19Eng-King Tan, Alberto Albanese, K Ray Chaudhuri, et al.
Neurology India|May 17, 2020
Neurosurgery and Neurology Practices during the Novel COVID-19 Pandemic: A Consensus Statement from IndiaPrakamya Gupta, N Muthukumar, V Rajshekhar, et al.
The Lancet. Neurology|August 16, 2024
Safety and efficacy of intra-erythrocyte dexamethasone sodium phosphate in children with ataxia telangiectasia (ATTeST): a multicentre, randomised, double-blind, placebo-controlled phase 3 trialStefan Zielen, Thomas Crawford, Luca Benatti, et al.
Pageof 2